NO985039L - Alkyl-4-silyl-fenoler og estere derav som antiatherosklerotiske midler - Google Patents
Alkyl-4-silyl-fenoler og estere derav som antiatherosklerotiske midlerInfo
- Publication number
- NO985039L NO985039L NO985039A NO985039A NO985039L NO 985039 L NO985039 L NO 985039L NO 985039 A NO985039 A NO 985039A NO 985039 A NO985039 A NO 985039A NO 985039 L NO985039 L NO 985039L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- hydrogen
- independently
- nr8r1
- trifluoromethyl
- Prior art date
Links
- 230000000879 anti-atherosclerotic effect Effects 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 abstract 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 abstract 1
- 102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 abstract 1
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 abstract 1
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006866 deterioration Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- -1 hydroxy, methoxy, ethoxy Chemical group 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 239000011368 organic material Substances 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 abstract 1
- 238000005502 peroxidation Methods 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/637,968 US5608095A (en) | 1996-04-30 | 1996-04-30 | Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
| PCT/US1997/003335 WO1997041129A1 (en) | 1996-04-30 | 1997-03-03 | Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO985039D0 NO985039D0 (no) | 1998-10-29 |
| NO985039L true NO985039L (no) | 1998-12-21 |
Family
ID=24558107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO985039A NO985039L (no) | 1996-04-30 | 1998-10-29 | Alkyl-4-silyl-fenoler og estere derav som antiatherosklerotiske midler |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5608095A (enExample) |
| EP (1) | EP0900225B1 (enExample) |
| JP (1) | JP4309473B2 (enExample) |
| KR (1) | KR100503181B1 (enExample) |
| CN (1) | CN1216993A (enExample) |
| AR (1) | AR006890A1 (enExample) |
| AT (1) | ATE212639T1 (enExample) |
| AU (1) | AU711322B2 (enExample) |
| BR (1) | BR9709190A (enExample) |
| CA (1) | CA2251991C (enExample) |
| DE (1) | DE69710191T2 (enExample) |
| DK (1) | DK0900225T3 (enExample) |
| ES (1) | ES2167716T3 (enExample) |
| IL (1) | IL126758A0 (enExample) |
| NO (1) | NO985039L (enExample) |
| PT (1) | PT900225E (enExample) |
| TW (1) | TW474940B (enExample) |
| WO (1) | WO1997041129A1 (enExample) |
| ZA (1) | ZA973503B (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5795876A (en) * | 1996-04-30 | 1998-08-18 | Hoechst Marion Rousssel, Inc. | Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols |
| KR20000065102A (ko) * | 1996-04-30 | 2000-11-06 | 게리 디. 스트리트, 스티븐 엘. 네스비트 | 2,6-디-알킬-4-실릴-페놀을사용한혈관세포흡착분자-1의억제방법및만성염증성질병의치료방법 |
| US6670398B2 (en) * | 1997-05-14 | 2003-12-30 | Atherogenics, Inc. | Compounds and methods for treating transplant rejection |
| EA200800375A1 (ru) * | 1997-05-14 | 2008-06-30 | Атеродженикс, Инк. | Соединения и способы ингибирования экспрессии vcam-1 |
| US6121463A (en) * | 1997-06-24 | 2000-09-19 | Hoechst Marion Roussel, Inc. | Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents |
| US6133467A (en) * | 1997-06-25 | 2000-10-17 | Hoechst Marion Roussel, Inc. | 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol |
| JP2002506443A (ja) * | 1997-06-25 | 2002-02-26 | アベンティス・ファーマスーティカルズ・インコーポレイテッド | ２，６−ジ−ｔ−ブチル−４−［（ジメチル−４−メトキシフェニルシリル）メチルオキシ］フェノール及び２，６−ジ−ｔ−ブチル−４−［（ジメチル−２−メトキシフェニルシリル）メチルオキシ］フェノール |
| KR20010020611A (ko) * | 1997-07-01 | 2001-03-15 | 아테로제닉스, 인코포레이티드 | 항산화제에 의한 과증식질병 치료의 향상 |
| US6887712B1 (en) | 1998-11-09 | 2005-05-03 | Atherogenics, Inc. | Methods and compositions to lower plasma cholesterol levels |
| CA2350316A1 (en) * | 1998-11-09 | 2000-05-18 | Atherogenics, Inc. | Methods and compositions to lower plasma cholesterol levels |
| US6020383A (en) * | 1999-01-11 | 2000-02-01 | Eastman Chemicals Company | Method for reducing blood cholesterol and/or blood triglycerides |
| WO2002040021A2 (en) | 2000-11-17 | 2002-05-23 | Idenix (Cayman) Limited | Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
| WO2002087556A2 (en) * | 2001-04-11 | 2002-11-07 | Atherogenics, Inc. | Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality |
| WO2003039231A2 (en) * | 2001-10-25 | 2003-05-15 | Atherogenics, Inc. | Compounds and methods for treating transplant rejection |
| IL161741A0 (en) * | 2001-11-09 | 2005-11-20 | Atherogenics Inc | Methods of reversing and preventingcardiovascular pathologies |
| CN1596240A (zh) * | 2001-12-19 | 2005-03-16 | 阿特罗吉尼克斯公司 | 查耳酮衍生物及其治疗疾病的用途 |
| AU2003253887A1 (en) * | 2002-07-12 | 2004-02-02 | Atherogenics, Inc. | Novel salt forms of poorly soluble probucol esters and ethers |
| US20040110803A1 (en) * | 2002-09-13 | 2004-06-10 | Hossein Dovlatabadi | Methods and compositions for the use of D-malic acid to decrease serum triglyceride, cholesterol and lipoprotein levels |
| WO2004056727A2 (en) * | 2002-12-19 | 2004-07-08 | Atherogenics, Inc. | Process of making chalcone derivatives |
| BRPI0406738A (pt) * | 2003-01-13 | 2005-12-20 | Atherogenics Inc | Processo de preparação de ésteres e éteres de probucol e derivados desse |
| WO2004108094A2 (en) * | 2003-06-06 | 2004-12-16 | Atherogenics, Inc. | Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
| WO2005039596A1 (en) * | 2003-10-17 | 2005-05-06 | Amylin Pharmaceuticals, Inc. | Silyl phenols for promoting vascular health |
| US7294737B2 (en) | 2004-04-20 | 2007-11-13 | Atherogenics, Inc. | Process of preparing esters and ethers of probucol and derivatives thereof |
| WO2005112914A2 (en) | 2004-04-20 | 2005-12-01 | Atherogenics, Inc. | Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease |
| US20060063828A1 (en) * | 2004-06-28 | 2006-03-23 | Weingarten M D | 1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof |
| AU2005262390B2 (en) * | 2004-07-01 | 2011-09-22 | Atherogenics, Inc. | Compounds and methods for treating diabetic vascular diseases |
| JP2010522762A (ja) * | 2007-03-26 | 2010-07-08 | サルトリア・フアーマシユーテイカルズ・エル・エル・シー | 糖尿病の治療のための方法及びプロブコール誘導体の組成物 |
| US20080280985A1 (en) * | 2007-03-27 | 2008-11-13 | Scott Robert A D | Methods and Compositions Using Certain Phenolic Derivatives for the Treatment of Diabetes |
| JP5778755B2 (ja) * | 2010-04-15 | 2015-09-16 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | ヒドロキノンの製造方法 |
| JP6447858B2 (ja) * | 2016-07-08 | 2019-01-09 | Ｙａｎｃｈｅｒｓ株式会社 | 固形癌治療剤 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3129262A (en) * | 1962-10-08 | 1964-04-14 | Consolidation Coal Co | Reduction of organic thiocyanates |
| US3862332A (en) * | 1967-05-11 | 1975-01-21 | Dow Chemical Co | Method of lowering serum cholesterol |
| US3576883A (en) * | 1969-06-30 | 1971-04-27 | Consolidation Coal Co | Alkylidenedithiobisphenols |
| US3897500A (en) * | 1971-12-10 | 1975-07-29 | Continental Oil Co | Alkylidenedithiobisphenols |
| US3786100A (en) * | 1971-12-10 | 1974-01-15 | Continental Oil Co | Keto substituted alkylidenedithiobisphenols |
| JPS61263988A (ja) * | 1985-05-16 | 1986-11-21 | Shionogi & Co Ltd | シリル置換エ−テル類および殺虫・殺ダニ剤 |
| US5356917A (en) * | 1985-08-09 | 1994-10-18 | Eli Lilly And Company | Aryl-substituted rhodanine derivatives |
| US4719237A (en) * | 1986-01-28 | 1988-01-12 | Merrell Dow Pharmaceuticals Inc. | Cardiac antiarrythmic method employing probucol |
| US4734527A (en) * | 1986-10-17 | 1988-03-29 | Merrell Dow Pharmaceuticals Inc. | Process for preparing 2,6-di-tertiarybutyl-4-mercaptophenol |
| US4772363A (en) * | 1987-01-14 | 1988-09-20 | Merrell Dow Pharmaceuticals Inc. | Process for preparing 2,6-di-tertiarybutyl-4-mercaptophenol by electrocatalysis |
| US4861443A (en) * | 1987-01-14 | 1989-08-29 | Merrell Dow Pharmaceuticals Inc. | Process for preparing 4,4'-isopropylidenedithio-bis-(2,6-di-tertiarybutylphenol) by electrocatalysis |
| US5401883A (en) * | 1987-01-20 | 1995-03-28 | Merrell Dow Pharmaceuticals Inc. | Process for preparing 2,6-di-tertiarybutyl-4-mercaptophenol and 4,4'-isopropylidenedithio-bis-(2,6-di-tertiarybutylphenol) |
| US4975467A (en) * | 1987-03-17 | 1990-12-04 | Merrell Dow Pharmaceuticals Inc. | Method of inhibiting interleukin-1 release and alleviating interleukin-1 mediated conditions |
| JPH0813824B2 (ja) * | 1988-10-27 | 1996-02-14 | 北興化学工業株式会社 | 有機ケイ素化合物 |
| US4900757A (en) * | 1988-12-08 | 1990-02-13 | Merrell Dow Pharmaceuticals Inc. | Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-tertiary-butyl-4-hydroxyphenylthio)methane |
| US5047555A (en) * | 1988-12-13 | 1991-09-10 | Tanabe Seiyaku Co., Ltd. | 4-aminophenol derivatives and processes for preparing the same |
| US5217870A (en) * | 1989-04-28 | 1993-06-08 | Biogen, Inc. | Monoclonal antibodies against CDX |
| US5272263A (en) * | 1989-04-28 | 1993-12-21 | Biogen, Inc. | DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
| US5008421A (en) * | 1989-07-05 | 1991-04-16 | Aristech Chemical Corporation | Silyl derivatives of 2,6-dimethyl-4-allyl phenol |
| DE3935638A1 (de) * | 1989-10-26 | 1991-05-02 | Consortium Elektrochem Ind | Organosilylalkylaromaten |
| US5061734A (en) * | 1990-05-09 | 1991-10-29 | Merrell Dow Pharmaceuticals Inc. | Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis |
| US5112870A (en) * | 1990-05-09 | 1992-05-12 | Merrell Dow Pharmaceuticals Inc. | Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis |
| JP2899064B2 (ja) * | 1990-05-23 | 1999-06-02 | キヤノン株式会社 | 液晶性化合物、これを含む液晶組成物およびこれを使用した液晶素子 |
| US5304668A (en) * | 1990-07-05 | 1994-04-19 | Merrell Dow Pharmaceuticals | Bis-[4-(2,6-di-alkyl)phenolisilane derivatives as antiatherosclerotic agents |
| US5155250A (en) * | 1990-07-05 | 1992-10-13 | Merrell Dow Pharmaceuticals Inc. | 2,6-di-alkyl-4-silyl-phenols as antiatheroscerotic agents |
| NZ238807A (en) * | 1990-07-05 | 1994-03-25 | Merrell Dow Pharma | Bis[4-(2,6-dialkyl)phenol]silane derivatives and antiatherosclerotic compositions |
| US5254549A (en) * | 1991-12-19 | 1993-10-19 | Merz & Co. Gmbh & Co. | New BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugs |
| US5262439A (en) * | 1992-04-30 | 1993-11-16 | The Regents Of The University Of California | Soluble analogs of probucol |
| NZ299210A (en) * | 1992-09-02 | 2000-08-25 | Isis Pharmaceuticals Inc | Treating diseases characterised by changes in intercellular adhesion molecules using coding sequences hybridizable with those encoding proteins involved in synthesis of such molecules |
| US5380747A (en) * | 1992-10-30 | 1995-01-10 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| USRE40811E1 (en) * | 1992-11-13 | 2009-06-30 | Board Of Regents Of The University Of Washington | Peripheralization of hematopoietic stem cells |
| AU5833494A (en) * | 1992-12-22 | 1994-07-19 | Smithkline Beecham Plc | Piperidine derivatives as calcium channel antagonists |
| SG44845A1 (en) * | 1993-01-12 | 1997-12-19 | Biogen Inc | Recombitant anti-vla4 antibody molecules |
| WO1994017828A2 (en) * | 1993-02-09 | 1994-08-18 | Biogen, Inc. | Treatment for insulin dependent diabetes |
| WO1995004749A1 (en) * | 1993-08-05 | 1995-02-16 | Isis Pharmaceuticals, Inc. | Oligomers for modulating metabolic function |
| JP3650144B2 (ja) * | 1994-06-08 | 2005-05-18 | 花王株式会社 | 細胞接着抑制剤 |
-
1996
- 1996-04-30 US US08/637,968 patent/US5608095A/en not_active Expired - Fee Related
-
1997
- 1997-03-03 IL IL12675897A patent/IL126758A0/xx unknown
- 1997-03-03 AU AU19854/97A patent/AU711322B2/en not_active Ceased
- 1997-03-03 JP JP53886297A patent/JP4309473B2/ja not_active Expired - Fee Related
- 1997-03-03 CA CA002251991A patent/CA2251991C/en not_active Expired - Fee Related
- 1997-03-03 BR BR9709190A patent/BR9709190A/pt active Search and Examination
- 1997-03-03 DE DE69710191T patent/DE69710191T2/de not_active Expired - Fee Related
- 1997-03-03 ES ES97907998T patent/ES2167716T3/es not_active Expired - Lifetime
- 1997-03-03 EP EP97907998A patent/EP0900225B1/en not_active Expired - Lifetime
- 1997-03-03 KR KR1019980708692A patent/KR100503181B1/ko not_active Expired - Fee Related
- 1997-03-03 CN CN97194267A patent/CN1216993A/zh active Pending
- 1997-03-03 AT AT97907998T patent/ATE212639T1/de not_active IP Right Cessation
- 1997-03-03 PT PT97907998T patent/PT900225E/pt unknown
- 1997-03-03 DK DK97907998T patent/DK0900225T3/da active
- 1997-03-03 WO PCT/US1997/003335 patent/WO1997041129A1/en not_active Ceased
- 1997-04-23 TW TW086105269A patent/TW474940B/zh active
- 1997-04-23 ZA ZA9703503A patent/ZA973503B/xx unknown
- 1997-04-29 AR ARP970101749A patent/AR006890A1/es unknown
-
1998
- 1998-10-29 NO NO985039A patent/NO985039L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT900225E (pt) | 2002-06-28 |
| IL126758A0 (en) | 1999-08-17 |
| KR100503181B1 (ko) | 2006-03-03 |
| DK0900225T3 (da) | 2002-05-13 |
| JP2001509782A (ja) | 2001-07-24 |
| CA2251991C (en) | 2002-05-14 |
| EP0900225A1 (en) | 1999-03-10 |
| US5608095A (en) | 1997-03-04 |
| BR9709190A (pt) | 1999-08-10 |
| DE69710191T2 (de) | 2002-07-25 |
| NO985039D0 (no) | 1998-10-29 |
| AU711322B2 (en) | 1999-10-14 |
| AU1985497A (en) | 1997-11-19 |
| KR20000065101A (ko) | 2000-11-06 |
| WO1997041129A1 (en) | 1997-11-06 |
| ES2167716T3 (es) | 2002-05-16 |
| ZA973503B (en) | 1997-10-30 |
| CN1216993A (zh) | 1999-05-19 |
| CA2251991A1 (en) | 1997-11-06 |
| DE69710191D1 (de) | 2002-03-14 |
| EP0900225B1 (en) | 2002-01-30 |
| TW474940B (en) | 2002-02-01 |
| AR006890A1 (es) | 1999-09-29 |
| JP4309473B2 (ja) | 2009-08-05 |
| ATE212639T1 (de) | 2002-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2251991A1 (en) | Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents | |
| DK1076663T3 (da) | Funktionaliserede alkyl- og alkenylsidekædederivater af glycinamider som farnesyltransferaseinhibitorer | |
| SE0000772D0 (sv) | Chemical compounds | |
| NO993868L (no) | 3-piperidyl-4-oksokinazolinderivater og farmasöytiske preparater omfattende samme | |
| DE69736642D1 (de) | Heterocyclische Verbindungen, ihre Herstellung und Verwendung | |
| DE69705480D1 (de) | Verwendung von Oestrogenagonisten und -antagonisten zur Herstellung eines Medikaments zur Behandlung von Atherosklerose, unabhängig von Lipidsenkung | |
| NO20055143L (no) | Doseringsformer innbefattende AG013736 | |
| FI915970A0 (fi) | Laekemedel, som aer nyttiga vid vaord av cancer och som har antihistaminegenskaper. | |
| DE69607650D1 (de) | 2,3,5-trimethyl-hydroxyanilid-derivative, ihre herstellung und ihre theraoeutische verwendung | |
| NO982770L (no) | FremgangsmÕte for fremstilling av piperidinderivater | |
| DE69925472D1 (de) | Benzoheterocyclische distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel | |
| NO20054095L (no) | Pyridyloksymetyl og benzioksazolazabicyklisk derivater | |
| EP1331224A4 (en) | THIAZOLE AND OXAZOLE DERIVATIVES | |
| CA2271054A1 (en) | Substituted phenols and thiophenols useful as antioxidant agents | |
| DK0732928T3 (da) | Fremgangsmåde til sænkning af serumcholesterolnuiveauer med 2,6-di-alkyl-4-silyl-phenoler | |
| HUP0100184A2 (hu) | Szubsztituált 2-(benzil-amino)-2-fenil-acetamid-vegyületek és ezeket tartalmazó gyógyszerkészítmények | |
| NO960441L (no) | Benzopyraner og farmasöytiske forbindelser inneholdende dem | |
| HRP20070030T3 (en) | Derivatives of benzothiazine and benzothiadiazine, procedure for their preparation and pharmaceutical compositions containing them | |
| MX9200485A (es) | Proceso para la obtencion de derivados de tetra hidro piridina y composicion farmaceutica que los contiene. | |
| ES455741A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 1,3-bencenodimetanol. | |
| NO961797L (no) | Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter | |
| HUP9900679A2 (hu) | Simaizom sejtburjánzást gátló benzimidazolszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| PT982305E (pt) | Novos derivados do indano-1-ol proceso para a sua preparacao e as composicoes farmaceuticas que os contem | |
| NO951072L (no) | Polyjoderte forbindelser, fremgangsmåte for deres fremstilling og diagnostisk preparat | |
| EA200101109A1 (ru) | Производные 1-трифторметил-4-гидрокси-7-пиперидинил-аминометилхромана |